Hologic, Navidea Biopharma, St. Jude Medical, and ResMed under AAAResearchReports.com Microscope

LONDON, July 25, 2013 /PRNewswire/ --

On Wednesday, July 24, 2013, shares in medical device companies ended mostly lower, tracking the broader market which also finished in the red. The major movers in the industry included Hologic Inc. (NASDAQ: HOLX), Navidea Biopharmaceuticals Inc. (AMEX: NAVB), St. Jude Medical Inc. (NYSE: STJ), and RedMed Inc. (NYSE: RMD). AAAResearchReports.com has released full comprehensive research on HOLX, NAVB, STJ, and RMD. These free technical analyses can be downloaded by signing up at:

http://www.aaaresearchreports.com/register/

Shares in Hologic Inc. fell sharply on Wednesday, reversing some of their gains for the week. The company's shares fluctuated between $22.50 and $23.00 before finishing the day 1.79% lower at $22.54. A total of 6.25 million shares were traded, which is above the daily average volume of 3.93 million. The stock has gained 4.01% so far this week as compared to a loss of 0.36% in the S&P 500. A free technical analysis on HOLX available by signing up at:

http://www.AAAResearchReports.com/HOLX072513.pdf

Navidea Biopharmaceuticals Inc.'s stock slipped on Wednesday, extending its losses for the week. The company's shares ended the day 0.34% lower at $2.97 after oscillating between $2.95 and $3.03. A total of 1.04 million shares were traded which is above the daily average volume of 764,922. Navidea's shares have fallen by 2.94% so far this week and 3.57% in the last one month. Register today and access free research on NAVB at:

http://www.AAAResearchReports.com/NAVB072513.pdf

Shares in St. Jude Medical Inc. edged lower on Wednesday, tracking losses in the broader market. The company's shares oscillated between $51.73 and $52.68 before ending the session 0.95% lower at $51.93. A total of 1.09 million shares were traded, which is less than the daily average volume of 2.24 million. Despite Wednesday's pullback, St. Jude Medical's shares have gained 0.46% so far this week, hence outperforming the S&P 500. Moreover, the stock is currently trading near its 52-week high of $52.72. The free report on STJ can be downloaded by signing up now at:

http://www.AAAResearchReports.com/STJ072513.pdf

RedMed Inc.'s stock fell sharply on Wednesday, finishing at $44.61, down 2.19% from its previous closing price. The company's shares fluctuated between $44.52 and $45.84. A total of 859,280 shares were traded, which is below the daily average volume of 1.06 million. RedMed's shares have fallen by 7.27% in the last one month and 2.49% in the last three months, underperforming the S&P 500. A free report on RMD can be accessed by registering at:

http://www.AAAResearchReports.com/RMD072513.pdf

EDITOR NOTES:

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider has, through Chartered Financial Analysts, only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE

Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

SOURCE AAA Research Reports